BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28864007)

  • 1. Expression pattern and phosphorylation status of Smad2/3 in different subtypes of human first trimester trophoblast.
    Haider S; Kunihs V; Fiala C; Pollheimer J; Knöfler M
    Placenta; 2017 Sep; 57():17-25. PubMed ID: 28864007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Role of Smad2 and Smad3 in the Acquisition of an Endovascular Trophoblast-Like Phenotype and Preeclampsia.
    Brkić J; Dunk C; Shan Y; O'Brien JA; Lye P; Qayyum S; Yang P; Matthews SG; Lye SJ; Peng C
    Front Endocrinol (Lausanne); 2020; 11():436. PubMed ID: 32733385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
    Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
    Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant TGFβ Signaling Contributes to Altered Trophoblast Differentiation in Preeclampsia.
    Xu J; Sivasubramaniyam T; Yinon Y; Tagliaferro A; Ray J; Nevo O; Post M; Caniggia I
    Endocrinology; 2016 Feb; 157(2):883-99. PubMed ID: 26653761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression pattern and function of Notch2 in different subtypes of first trimester cytotrophoblast.
    Plessl K; Haider S; Fiala C; Pollheimer J; Knöfler M
    Placenta; 2015 Apr; 36(4):365-71. PubMed ID: 25659500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extravillous trophoblast invasion of venous as well as lymphatic vessels is altered in idiopathic, recurrent, spontaneous abortions.
    Windsperger K; Dekan S; Pils S; Golletz C; Kunihs V; Fiala C; Kristiansen G; Knöfler M; Pollheimer J
    Hum Reprod; 2017 Jun; 32(6):1208-1217. PubMed ID: 28369440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone morphogenetic protein 2 promotes human trophoblast cell invasion by upregulating N-cadherin via non-canonical SMAD2/3 signaling.
    Zhao HJ; Klausen C; Li Y; Zhu H; Wang YL; Leung PCK
    Cell Death Dis; 2018 Feb; 9(2):174. PubMed ID: 29416020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceleration of Smad2 and Smad3 phosphorylation via c-Jun NH(2)-terminal kinase during human colorectal carcinogenesis.
    Yamagata H; Matsuzaki K; Mori S; Yoshida K; Tahashi Y; Furukawa F; Sekimoto G; Watanabe T; Uemura Y; Sakaida N; Yoshioka K; Kamiyama Y; Seki T; Okazaki K
    Cancer Res; 2005 Jan; 65(1):157-65. PubMed ID: 15665291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trophoblast subtype-specific EGFR/ERBB4 expression correlates with cell cycle progression and hyperplasia in complete hydatidiform moles.
    Fock V; Plessl K; Fuchs R; Dekan S; Milla SK; Haider S; Fiala C; Knöfler M; Pollheimer J
    Hum Reprod; 2015 Apr; 30(4):789-99. PubMed ID: 25740878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 1 β-induced SMAD2/3 linker modifications are TAK1 dependent and delay TGFβ signaling in primary human mesenchymal stem cells.
    van den Akker GG; van Beuningen HM; Vitters EL; Koenders MI; van de Loo FA; van Lent PL; Blaney Davidson EN; van der Kraan PM
    Cell Signal; 2017 Dec; 40():190-199. PubMed ID: 28943409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activin A, B, and AB increase human trophoblast cell invasion by up-regulating N-cadherin.
    Li Y; Klausen C; Cheng JC; Zhu H; Leung PC
    J Clin Endocrinol Metab; 2014 Nov; 99(11):E2216-25. PubMed ID: 25105734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch-dependent RBPJκ inhibits proliferation of human cytotrophoblasts and their differentiation into extravillous trophoblasts.
    Velicky P; Haider S; Otti GR; Fiala C; Pollheimer J; Knöfler M
    Mol Hum Reprod; 2014 Aug; 20(8):756-66. PubMed ID: 24850908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAM8 localizes to extravillous trophoblasts within the maternal-fetal interface and potentiates trophoblast cell line migration through a β1 integrin-mediated mechanism.
    Le HT; Atif J; Mara DL; Castellana B; Treissman J; Baltayeva J; Beristain AG
    Mol Hum Reprod; 2018 Oct; 24(10):495-509. PubMed ID: 30124911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel trophoblast invasion-related genes: heme oxygenase-1 controls motility via peroxisome proliferator-activated receptor gamma.
    Bilban M; Haslinger P; Prast J; Klinglmüller F; Woelfel T; Haider S; Sachs A; Otterbein LE; Desoye G; Hiden U; Wagner O; Knöfler M
    Endocrinology; 2009 Feb; 150(2):1000-13. PubMed ID: 18845641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt-dependent T-cell factor-4 controls human etravillous trophoblast motility.
    Meinhardt G; Haider S; Haslinger P; Proestling K; Fiala C; Pollheimer J; Knöfler M
    Endocrinology; 2014 May; 155(5):1908-20. PubMed ID: 24605829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myostatin increases human trophoblast cell invasion by upregulating N-cadherin via SMAD2/3-SMAD4 signaling†.
    AbdelHafez F; Klausen C; Zhu H; Leung PCK
    Biol Reprod; 2022 Jun; 106(6):1267-1277. PubMed ID: 35020826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-specific and ubiquitous basic helix-loop-helix transcription factors in human placental trophoblasts.
    Meinhardt G; Husslein P; Knöfler M
    Placenta; 2005 Aug; 26(7):527-39. PubMed ID: 15993702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad3 gene C-terminal phosphorylation site mutation exacerbates CCl
    Yang J; Gong Y; Xu W; Li L; Shi Z; Wang Q; He Y; Zhang C; Luo C; Fang Z; Yang Y
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Aug; 394(8):1779-1786. PubMed ID: 34191114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-β signaling governs the differentiation program of extravillous trophoblasts in the developing human placenta.
    Haider S; Lackner AI; Dietrich B; Kunihs V; Haslinger P; Meinhardt G; Maxian T; Saleh L; Fiala C; Pollheimer J; Latos PA; Knöfler M
    Proc Natl Acad Sci U S A; 2022 Jul; 119(28):e2120667119. PubMed ID: 35867736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astragaloside IV inhibits hepatocellular carcinoma by continually suppressing the development of fibrosis and regulating pSmad3C/3L and Nrf2/HO-1 pathways.
    Zhang C; Li L; Hou S; Shi Z; Xu W; Wang Q; He Y; Gong Y; Fang Z; Yang Y
    J Ethnopharmacol; 2021 Oct; 279():114350. PubMed ID: 34157326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.